$ETSY

Silverman Josh sold $5.7M of ETSY

Silverman Josh sold 81,980 shares of ETSY INC (ETSY) at $69.09 ($5.66M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Silverman Josh
Published Jun 3, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 3, 2026, 8:42 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ETSY
Neutral
medium confidence
Mentioned
$ETSY
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ETSYNeutralLow
01

Why it matters

This is a disclosed ownership change, not an operational or financial update; the main tradable angle is short-term sentiment/positioning around insider activity.

02

Market read

Traders may monitor insider activity for sentiment, but 10b5-1 typically limits the signal’s strength absent other news.

03

What to watch

Size of the sale vs. total holdings and whether future scheduled sales exist could matter more than the single datapoint.

Relevance 6/10Novelty 6/10Timing: Filed June 3; transaction dated June 1 (post-trade disclosure).

Background

SEC Form 4 insider transaction disclosure: director Josh Silverman sold ETSY shares on June 1 under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$ETSYNeutralMedium confidence
Context

Etsy director Josh Silverman sold 81,980 shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Low near-term impact; any reaction is likely sentiment-driven and should fade unless accompanied by other catalysts.

Evidence & confidence

The filing provides a specific sale datapoint but does not indicate distress or a new company event; 10b5-1 typically reduces interpretive weight.

Market effects

Minimal—single-company insider Form 4 without broader sector/regulatory implications.

None indicated.

None indicated.

Counterpoint

Because the sale was pre-arranged (10b5-1), it may reflect routine liquidity planning rather than bearish expectations; any selloff may be overdone.

Key entities

  • ETSY

    Etsy, Inc.; shares sold by a director via open-market transaction under a 10b5-1 plan.

  • Josh Silverman

    Director who sold 81,980 shares at $69.09/share; holdings after sale: 130,694 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$WMTMed

Retailers Report AI-Driven Sales, Bigger Baskets in Q2 Earnings

Walmart, Amazon, and Target reported Q2 earnings showing AI-driven sales growth. Walmart's eCommerce grew 23%, with AI assistant users spending 40% more. Amazon's Alexa for Shopping saw active users nearly double. Target's digital traffic from AI platforms grew over 3.5x faster than the industry average. Albertsons saw a 10-26% increase in order value with AI tools. Shopify's AI-referred traffic and orders tripled, but AI's impact on discovery-driven retail remains uncertain.

$ETSYHigh

Bank of America Resets Etsy Stock Price Target After Event

Bank of America upgraded Etsy to Buy, raising its price target to $105 from $88, citing structural growth. The bank expects mid-single-digit gross merchandise sales growth, higher profitability, and increased shareholder returns. Etsy's new management team is seen as key to reinvigorating growth. BofA raised its fiscal 2027 estimates for gross merchandise sales, EBITDA, and EPS.

$DEMed

Premarket movers: Deere jumps following upbeat Q3, Wolfspeed plunges

Deere shares rose 5.1% after reporting stronger-than-expected Q3 results, with EPS of $5.10 and net sales of $11B. CrowdStrike fell 2.8% following its CTO's departure. Advance Auto Parts dropped 15.9% due to lower normalized earnings. Etsy gained 3.9% after a BofA upgrade. Ultragenyx surged 11.1% on FDA approval for a gene therapy. Moderna fell 13% after a prior surge. Wolfspeed plunged 10.5% on wider-than-expected Q4 loss. Webull rose 13.8% on strong Q2 results.